drugset / Trial / NCT00790881

Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults

NCT00790881

Parallel-groupOpen-labelTreatment

Summary

Despite the clinical significance of potential interactions between antimalarials and antiretrovirals, no drug interaction studies have been published and there is an urgent need to address this gap in current knowledge. This study aims to assess the drug interaction between the antimalarial Artemether/Lumefantrine used for management of uncomplicated malaria and Nevirapine-based antiretroviral therapy.

Timeline

Start
2008-10
Primary completion
2009-08
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether Small molecule 80 mg
Subject lumefantrine Small molecule 480 mg